efavirenz and Depression, Endogenous

efavirenz has been researched along with Depression, Endogenous in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Patel, TK; Patel, VB; Rana, DG	1
Delmas, B; Lochet, P; Lotthé, A; Mauboussin, JM; Peyrière, H; Reynes, J	1
Allard, C; Cassuto, JP; Chene, G; De Castro, N; Garré, M; Journot, V; Molina, JM; Rancinan, C; Sobel, A; Vildé, JL	1

Trials

1 trial(s) available for efavirenz and Depression, Endogenous

Article	Year
Use of efavirenz is not associated with a higher risk of depressive disorders: a substudy of the randomized clinical trial ALIZE-ANRS 099. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Jun-15, Volume: 42, Issue:12 Topics: Adult; Aging; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Depressive Disorder; Female; HIV Protease Inhibitors; Humans; Male; Middle Aged; Oxazines; Risk Factors; Suicide	2006

Article

Year

Use of efavirenz is not associated with a higher risk of depressive disorders: a substudy of the randomized clinical trial ALIZE-ANRS 099.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Jun-15, Volume: 42, Issue:12

Topics: Adult; Aging; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Depressive Disorder; Female; HIV Protease Inhibitors; Humans; Male; Middle Aged; Oxazines; Risk Factors; Suicide

2006

Other Studies

2 other study(ies) available for efavirenz and Depression, Endogenous

Article	Year
Possible anti-depressant effect of efavirenz and pro-depressive-like effect of voriconazole in specified doses in various experimental models of depression in mice. Pharmacological reports : PR, 2017, Volume: 69, Issue:5 Topics: Alkynes; Animals; Antifungal Agents; Behavior, Animal; Benzoxazines; Brain; Cyclopropanes; Depressive Disorder; Disease Models, Animal; Male; Mice; Reverse Transcriptase Inhibitors; Stress, Psychological; Swimming; Voriconazole	2017
Long-term assessment of neuropsychiatric adverse reactions associated with efavirenz. HIV medicine, 2003, Volume: 4, Issue:1 Topics: Adolescent; Adult; Aged; Alkynes; Anti-HIV Agents; Anxiety Disorders; Benzoxazines; Cognition Disorders; Cyclopropanes; Depressive Disorder; Female; Follow-Up Studies; HIV Infections; Humans; Male; Mental Disorders; Middle Aged; Mood Disorders; Oxazines; Quality of Life; Sleep Wake Disorders; Surveys and Questionnaires	2003

Article

Year

Possible anti-depressant effect of efavirenz and pro-depressive-like effect of voriconazole in specified doses in various experimental models of depression in mice.

Pharmacological reports : PR, 2017, Volume: 69, Issue:5

Topics: Alkynes; Animals; Antifungal Agents; Behavior, Animal; Benzoxazines; Brain; Cyclopropanes; Depressive Disorder; Disease Models, Animal; Male; Mice; Reverse Transcriptase Inhibitors; Stress, Psychological; Swimming; Voriconazole

2017

Long-term assessment of neuropsychiatric adverse reactions associated with efavirenz.

HIV medicine, 2003, Volume: 4, Issue:1

Topics: Adolescent; Adult; Aged; Alkynes; Anti-HIV Agents; Anxiety Disorders; Benzoxazines; Cognition Disorders; Cyclopropanes; Depressive Disorder; Female; Follow-Up Studies; HIV Infections; Humans; Male; Mental Disorders; Middle Aged; Mood Disorders; Oxazines; Quality of Life; Sleep Wake Disorders; Surveys and Questionnaires

2003